Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:07 am Sale |
2024-12-31 | 13G | Moderna, Inc. MRNA |
BAILLIE GIFFORD & CO | 38,889,571 10.100% |
-6,764,956 (-14.82%) |
Filing History |
| 2024-04-10 2:03 pm Purchase |
2024-03-28 | 13G | Moderna, Inc. MRNA |
The Vanguard Group | 39,036,765 10.200% |
5,129,791 (+15.13%) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Moderna, Inc. MRNA |
The Vanguard Group | 33,906,974 8.890% |
6,624,801 (+24.28%) |
Filing History |
| 2024-02-07 08:42 am Purchase |
2023-12-31 | 13G | Moderna, Inc. MRNA |
Bancel Stephane | 30,384,866 7.800% |
1,233,064 (+4.23%) |
Filing History |
| 2024-01-29 3:26 pm Sale |
2023-12-31 | 13G | Moderna, Inc. MRNA |
BLACKROCK INC BLK |
25,301,057 6.600% |
-814,167 (-3.12%) |
Filing History |
| 2024-01-29 10:49 am Purchase |
2023-12-29 | 13G | Moderna, Inc. MRNA |
BAILLIE GIFFORD & CO | 45,654,527 11.970% |
867,781 (+1.94%) |
Filing History |
| 2023-02-10 4:42 pm Sale |
2022-12-31 | 13G | Moderna, Inc. MRNA |
Bancel Stephane | 29,151,802 7.410% |
-2,386,382 (-7.57%) |
Filing History |
| 2023-02-09 11:27 am Sale |
2022-12-30 | 13G | Moderna, Inc. MRNA |
The Vanguard Group | 27,282,173 7.100% |
-144,397 (-0.53%) |
Filing History |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | Moderna, Inc. MRNA |
BLACKROCK INC BLK |
26,115,224 6.800% |
-1,546,249 (-5.59%) |
Filing History |
| 2023-01-19 11:25 am Sale |
2022-12-30 | 13G | Moderna, Inc. MRNA |
BAILLIE GIFFORD & CO | 44,786,746 11.660% |
-985,333 (-2.15%) |
Filing History |
| 2022-02-14 3:00 pm Sale |
2021-12-31 | 13G | Moderna, Inc. MRNA |
Flagship Ventures Fund IV General Partner LLC | 20,008,540 4.900% |
-13,134,971 (-39.63%) |
Filing History |
| 2022-02-14 08:01 am Purchase |
2021-12-31 | 13G | Moderna, Inc. MRNA |
Bancel Stephane | 31,538,184 7.640% |
2,878,726 (+10.04%) |
Filing History |
| 2022-02-10 08:27 am Purchase |
2021-12-31 | 13G | Moderna, Inc. MRNA |
The Vanguard Group | 27,426,570 6.760% |
4,054,715 (+17.35%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Moderna, Inc. MRNA |
BLACKROCK INC BLK |
27,661,473 6.800% |
8,270,748 (+42.65%) |
Filing History |
| 2022-01-26 10:26 am Purchase |
2021-12-31 | 13G | Moderna, Inc. MRNA |
BAILLIE GIFFORD & CO | 45,772,079 11.290% |
1,080,693 (+2.42%) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Moderna, Inc. MRNA |
BLACKROCK INC BLK |
19,390,725 4.800% |
-1,085,989 (-5.30%) |
Filing History |
| 2021-03-01 11:26 am Purchase |
2021-02-26 | 13G | Moderna, Inc. MRNA |
BAILLIE GIFFORD & CO | 44,691,386 11.180% |
20,379,115 (+83.82%) |
Filing History |
| 2021-02-16 5:02 pm Sale |
2020-12-31 | 13G | Moderna, Inc. MRNA |
Flagship Ventures Fund IV General Partner LLC | 33,143,511 8.400% |
-17,865,181 (-35.02%) |
Filing History |
| 2021-02-12 08:00 am Sale |
2020-12-31 | 13G | Moderna, Inc. MRNA |
Bancel Stephane | 28,659,458 7.090% |
-2,940,318 (-9.30%) |
Filing History |
| 2021-02-10 4:01 pm Sale |
2020-12-31 | 13G | Moderna, Inc. MRNA |
ASTRAZENECA PLC | 0 0.000% |
-25,499,325 (Position Closed) |
Filing History |